FR2669821B1 - - Google Patents

Info

Publication number
FR2669821B1
FR2669821B1 FR9015171A FR9015171A FR2669821B1 FR 2669821 B1 FR2669821 B1 FR 2669821B1 FR 9015171 A FR9015171 A FR 9015171A FR 9015171 A FR9015171 A FR 9015171A FR 2669821 B1 FR2669821 B1 FR 2669821B1
Authority
FR
France
Prior art keywords
denotes
phenylethanolaminotetralins
prophylaxis
depression
stress
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9015171A
Other languages
English (en)
French (fr)
Other versions
FR2669821A1 (fr
Inventor
Peter-Eugene Keane
Alberto Bianchetti
Jacques Simiand
Tiziano Croci
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi SA
Original Assignee
Sanofi SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR9015171A priority Critical patent/FR2669821A1/fr
Application filed by Sanofi SA filed Critical Sanofi SA
Priority to SG1996001786A priority patent/SG47450A1/en
Priority to EP91403263A priority patent/EP0489640B1/fr
Priority to IE419591A priority patent/IE76322B1/en
Priority to DE69122480T priority patent/DE69122480T2/de
Priority to AT91403263T priority patent/ATE143592T1/de
Priority to DK91403263.6T priority patent/DK0489640T3/da
Priority to CA002056906A priority patent/CA2056906C/en
Priority to AU88395/91A priority patent/AU653968B2/en
Priority to JP3320532A priority patent/JP2610735B2/ja
Priority to US07/804,580 priority patent/US5270341A/en
Priority to MX9102365A priority patent/MX9102365A/es
Priority to HU913800A priority patent/HU207793B/hu
Publication of FR2669821A1 publication Critical patent/FR2669821A1/fr
Application granted granted Critical
Publication of FR2669821B1 publication Critical patent/FR2669821B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR9015171A 1990-12-04 1990-12-04 Utilisation de phenylethanolaminotetralines pour la preparation de medicaments destines au traitement de la depression. Granted FR2669821A1 (fr)

Priority Applications (13)

Application Number Priority Date Filing Date Title
FR9015171A FR2669821A1 (fr) 1990-12-04 1990-12-04 Utilisation de phenylethanolaminotetralines pour la preparation de medicaments destines au traitement de la depression.
EP91403263A EP0489640B1 (fr) 1990-12-04 1991-12-03 Utilisation de phényléthanolaminotétralines pour la préparation de médicaments antidépressifs et anti-stress
IE419591A IE76322B1 (en) 1990-12-04 1991-12-03 Use of phenylethanolaminotetralines for preparing antidepressant and anti-stress medicines
DE69122480T DE69122480T2 (de) 1990-12-04 1991-12-03 Verwendung von Phenyläthanolaminotetralinen zur Herstellung eines antidepressiven und Antistress-Arzneimittels
AT91403263T ATE143592T1 (de) 1990-12-04 1991-12-03 Verwendung von phenyläthanolaminotetralinen zur herstellung eines antidepressiven und antistress- arzneimittels
DK91403263.6T DK0489640T3 (da) 1990-12-04 1991-12-03 Anvendelse af phenylethanolaminotetraliner til fremstilling af antidepressive lægemidler og anti-stress-lægemidler
SG1996001786A SG47450A1 (en) 1990-12-04 1991-12-03 Use of phenylethanolaminotetralins for the preparation of antidepressant and anti-stress medicaments
CA002056906A CA2056906C (en) 1990-12-04 1991-12-04 Use of phenylethanolaminotetralins for the preparation of anti-depressant and anti-stress pharmaceutical compositions
AU88395/91A AU653968B2 (en) 1990-12-04 1991-12-04 Use of phenylethanolaminotetralins for the preparation of anti-depressant and anti-stress pharmaceutical compositions
JP3320532A JP2610735B2 (ja) 1990-12-04 1991-12-04 抗鬱剤および抗ストレス剤組成物
US07/804,580 US5270341A (en) 1990-12-04 1991-12-04 Method of treatment or prophylaxis of depression and stress
MX9102365A MX9102365A (es) 1990-12-04 1991-12-04 Composicion farmaceutica que contiene fenil etanolcomposicion farmaceutica que contiene fenil etanol amino tetralinas. amino tetralinas.
HU913800A HU207793B (en) 1990-12-04 1991-12-04 Process for producing antidepressant and antistress active pharmaceutical compositions containingphenyl-ethanol-amino-tetralines

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9015171A FR2669821A1 (fr) 1990-12-04 1990-12-04 Utilisation de phenylethanolaminotetralines pour la preparation de medicaments destines au traitement de la depression.

Publications (2)

Publication Number Publication Date
FR2669821A1 FR2669821A1 (fr) 1992-06-05
FR2669821B1 true FR2669821B1 (https=) 1994-12-09

Family

ID=9402882

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9015171A Granted FR2669821A1 (fr) 1990-12-04 1990-12-04 Utilisation de phenylethanolaminotetralines pour la preparation de medicaments destines au traitement de la depression.

Country Status (13)

Country Link
US (1) US5270341A (https=)
EP (1) EP0489640B1 (https=)
JP (1) JP2610735B2 (https=)
AT (1) ATE143592T1 (https=)
AU (1) AU653968B2 (https=)
CA (1) CA2056906C (https=)
DE (1) DE69122480T2 (https=)
DK (1) DK0489640T3 (https=)
FR (1) FR2669821A1 (https=)
HU (1) HU207793B (https=)
IE (1) IE76322B1 (https=)
MX (1) MX9102365A (https=)
SG (1) SG47450A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2826651B1 (fr) * 2001-06-28 2005-09-02 Sanofi Synthelabo Forme cristalline d'une phenylethanolamine, sa preparation et compositions pharmaceutiques la contenant
EP1623705A1 (en) * 2004-07-09 2006-02-08 Sanofi-Aventis Use of phenylethanolaminotetralines for preparing anxiolytic drugs
FR2890862B1 (fr) * 2005-09-19 2008-01-25 Sanofi Aventis Sa Association d'agoniste aux recepteurs beta 3 et d'inhibiteur de la recapture de monoamnies, compostion pharmaceutique la contenant et son utilisation en therapeutique.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH637363A5 (en) * 1977-11-24 1983-07-29 Sandoz Ag Process for preparing novel 2-aminotetralins
FR2584712B1 (fr) * 1985-07-10 1987-11-27 Midy Spa Phenylethanolamines a activite lipolytique, un procede pour leur preparation et compositions pharmaceutiques en contenant
IL79323A (en) * 1985-07-10 1990-03-19 Sanofi Sa Phenylethanolaminotetralines,their preparation and pharmaceutical compositions containing them
US4927955A (en) * 1987-08-12 1990-05-22 Sanofi Process for the O-alkylation of N-(hydroxy)aralkylphenylethanolamines
DE3872100T2 (de) * 1987-08-12 1993-01-28 Sanofi Elf Verfahren zur herstellung von phenylaethanolaminotetralinen.
EP0452390B1 (en) * 1989-01-09 1994-10-26 The Upjohn Company Halo substituted aminotetralins
FR2643076B1 (fr) * 1989-02-14 1991-06-21 Midy Spa Carboxyalkyl-ethers de la 2-amino-7-hydroxytetraline
DE69028877T2 (de) * 1989-06-13 1997-02-27 Sanofi Sa Verwendung von Phenylethanolaminen zur Herstellung von Medikamenten gegen Augenleiden

Also Published As

Publication number Publication date
EP0489640B1 (fr) 1996-10-02
DE69122480T2 (de) 1997-04-24
JPH0525040A (ja) 1993-02-02
HUT59595A (en) 1992-06-29
JP2610735B2 (ja) 1997-05-14
SG47450A1 (en) 1998-04-17
US5270341A (en) 1993-12-14
CA2056906A1 (en) 1992-06-05
DK0489640T3 (da) 1997-02-17
IE914195A1 (en) 1992-06-17
AU653968B2 (en) 1994-10-20
HU207793B (en) 1993-06-28
IE76322B1 (en) 1997-10-22
DE69122480D1 (de) 1996-11-07
EP0489640A1 (fr) 1992-06-10
FR2669821A1 (fr) 1992-06-05
AU8839591A (en) 1992-06-11
CA2056906C (en) 1998-04-28
HU913800D0 (en) 1992-02-28
ATE143592T1 (de) 1996-10-15
MX9102365A (es) 1992-09-01

Similar Documents

Publication Publication Date Title
AU7998291A (en) Antiatherosclerotic and antithrombotic 1-benzopyran-4-ones and 2-amino-1,3-benzoxazine-4-ones
GR1002642B (el) Ελαστομερης ιατρικη συσκευη.
GB8817137D0 (en) Compositions
MX9701325A (es) Metodos para inhibir la mucositis ulcerativa.
ES2104090T3 (es) Nuevas 3',5'-di-t-butil-4'-hidroxi-flavonas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
AU596982B2 (en) Acrylic diesters of bisphenol alkyl ether, polymers prepared therefrom and composites for dental use
FR2704226B1 (fr) 3-desoxy oligosaccharides, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
CS530585A2 (en) Zpusob vyroby 2 substituovanych 1,3 propylidendifosfonatovych derivatu
GR3007118T3 (https=)
AU1029588A (en) Synergistic combination of azelastine and theophylline or azelastine and beta-mimetics
FR2669821B1 (https=)
AU1183783A (en) Pyriod (3,4-c),psoralens
GR3003738T3 (https=)
ZA912204B (en) Method for the study of internal body tissues
AU6306886A (en) Alkylcarboxamides of pyridylalkylamines, their preparation and their use in human and veterinary medicine
IL113451A0 (en) A proces for the preparation of 5, 6 - dihydroxy -2- amino - 1, 2, 3, 4 - tetrahydronaphthalene derivatives
EP0785193A4 (en) ARYLTHIADIAZOLE DERIVATIVES AND ANTIVIRAL PRODUCTS CONTAINING THEM
AU8508991A (en) Use of 4-hydroxyphenyl-thioethers for stimulating superoxide generation
GR3005231T3 (https=)
FR2708604A1 (fr) Utilisation de dérivés de benzènesulfonyl-indole pour la préparation de médicaments.
FR2493846B1 (https=)
PL290086A1 (en) Agent for protecting cultures of microorganisms against phagolysis
ZA9010182B (en) Use of aminoxides as antistatic agents
ES2031032A6 (es) Perfeccionamientos introducidos en la patente de invencion n{ 9000839 que se refiere a "soporte para sobreponer a las baneras" .
EP0412941A3 (en) Phospholipids for the treatment of multiple sclerosis

Legal Events

Date Code Title Description
ST Notification of lapse